Unknown

Dataset Information

0

Topsentinol L Trisulfate, a Marine Natural Product That Targets Basal-like and Claudin-Low Breast Cancers.


ABSTRACT: Patients diagnosed with basal-like breast cancer suffer from poor prognosis and limited treatment options. There is an urgent need to identify new targets that can benefit patients with basal-like and claudin-low (BL-CL) breast cancers. We screened fractions from our Marine Invertebrate Compound Library (MICL) to identify compounds that specifically target BL-CL breast cancers. We identified a previously unreported trisulfated sterol, i.e., topsentinol L trisulfate (TLT), which exhibited increased efficacy against BL-CL breast cancers relative to luminal/HER2+ breast cancer. Biochemical investigation of the effects of TLT on BL-CL cell lines revealed its ability to inhibit activation of AMP-activated protein kinase (AMPK) and checkpoint kinase 1 (CHK1) and to promote activation of p38. The importance of targeting AMPK and CHK1 in BL-CL cell lines was validated by treating a panel of breast cancer cell lines with known small molecule inhibitors of AMPK (dorsomorphin) and CHK1 (Ly2603618) and recording the increased effectiveness against BL-CL breast cancers as compared with luminal/HER2+ breast cancer. Finally, we generated a drug response gene-expression signature and projected it against a human tumor panel of 12 different cancer types to identify other cancer types sensitive to the compound. The TLT sensitivity gene-expression signature identified breast and bladder cancer as the most sensitive to TLT, while glioblastoma multiforme was the least sensitive.

SUBMITTER: El-Chaar NN 

PROVIDER: S-EPMC7831112 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Topsentinol L Trisulfate, a Marine Natural Product That Targets Basal-like and Claudin-Low Breast Cancers.

El-Chaar Nader N NN   Smith Thomas E TE   Shrestha Gajendra G   Piccolo Stephen R SR   Harper Mary Kay MK   Van Wagoner Ryan M RM   Lu Zhenyu Z   Venancio Ashlee R AR   Ireland Chris M CM   Bild Andrea H AH   Moos Philip J PJ  

Marine drugs 20210118 1


Patients diagnosed with basal-like breast cancer suffer from poor prognosis and limited treatment options. There is an urgent need to identify new targets that can benefit patients with basal-like and claudin-low (BL-CL) breast cancers. We screened fractions from our Marine Invertebrate Compound Library (MICL) to identify compounds that specifically target BL-CL breast cancers. We identified a previously unreported trisulfated sterol, i.e., topsentinol L trisulfate (TLT), which exhibited increas  ...[more]

Similar Datasets

| S-EPMC4197217 | biostudies-literature
| S-EPMC7996939 | biostudies-literature
| S-EPMC3648081 | biostudies-other
| S-EPMC9313812 | biostudies-literature
| S-EPMC5207440 | biostudies-literature
| S-EPMC5749289 | biostudies-literature
| S-EPMC4820311 | biostudies-literature
| S-EPMC4717616 | biostudies-literature
| S-EPMC3069200 | biostudies-literature
| S-EPMC9050630 | biostudies-literature